STAT+: In new FDA role, Pazdur will decide the future of Sarepta’s Duchenne drugs

And other health news today from the Morning Rounds newsletter

The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly lower than the all-time high reached in 2024

Plus more biotech news updates, brought to you by The Readout

Researchers and advocates fear a key autism committee is being reshaped to support Kennedy's vaccine agenda.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Over 60 health systems asked national health record exchanges to take action to prevent “bad actors” from accessing patients’ health information.

Health insurance execs blame the high cost of health care on hospitals, doctors, and prescription drugs.

The Trump administration announced Thursday that human fetal tissue derived from abortions can no longer be used in NIH-funded research.